InflaRx NVNASDAQ:IFRX
- LAST PRICE1.3400
- TODAY'S CHANGE (%)-0.0500 (-3.5971%)
- Bid / Lots1.3200/ 12
- Ask / Lots1.3600/ 2
- Open / Previous Close1.4100 / 1.3900
- Day Range
- 52 Week Range
- Volume51,310
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | IFRX |
|---|---|---|
| 09:38 ET | 800 | 1.42 |
| 09:41 ET | 400 | 1.36 |
| 09:43 ET | 300 | 1.35 |
| 09:56 ET | 409 | 1.429 |
| 09:59 ET | 1006 | 1.39 |
| 10:10 ET | 100 | 1.37 |
| 10:19 ET | 200 | 1.4 |
| 10:24 ET | 210 | 1.375 |
| 10:28 ET | 100 | 1.36 |
| 10:30 ET | 500 | 1.3616 |
| 10:32 ET | 100 | 1.36 |
| 10:35 ET | 100 | 1.36 |
| 10:42 ET | 100 | 1.37 |
| 10:46 ET | 100 | 1.37 |
| 10:48 ET | 100 | 1.375 |
| 10:50 ET | 200 | 1.37 |
| 11:00 ET | 100 | 1.37 |
| 11:02 ET | 1090 | 1.38 |
| 11:08 ET | 300 | 1.37 |
| 11:15 ET | 300 | 1.4 |
| 11:18 ET | 200 | 1.37 |
| 11:26 ET | 300 | 1.37 |
| 11:31 ET | 100 | 1.4 |
| 11:36 ET | 300 | 1.37 |
| 11:44 ET | 100 | 1.37 |
| 11:47 ET | 100 | 1.37 |
| 11:51 ET | 100 | 1.37 |
| 11:54 ET | 100 | 1.375 |
| 11:58 ET | 100 | 1.37 |
| 12:00 ET | 430 | 1.39 |
| 12:03 ET | 1829 | 1.36 |
| 12:05 ET | 2600 | 1.35 |
| 12:07 ET | 600 | 1.38 |
| 12:12 ET | 1500 | 1.36 |
| 12:32 ET | 200 | 1.35 |
| 12:54 ET | 100 | 1.35 |
| 12:57 ET | 100 | 1.355 |
| 01:06 ET | 200 | 1.35 |
| 01:19 ET | 100 | 1.37 |
| 01:26 ET | 300 | 1.36 |
| 01:32 ET | 100 | 1.35 |
| 01:37 ET | 100 | 1.35 |
| 01:42 ET | 100 | 1.37 |
| 01:44 ET | 10699 | 1.36 |
| 01:46 ET | 360 | 1.35 |
| 01:48 ET | 1716 | 1.36 |
| 01:50 ET | 300 | 1.365 |
| 01:51 ET | 100 | 1.365 |
| 02:06 ET | 16992 | 1.34 |
Apr 24, 2024
InflaRx to Participate in Capital One Securities 1st Annual Biotech/Biopharma Disrupters Event, from 7:30AM ET on Wednesday Apr 24, 2024 by Dow Jones
7:30AM ET on Wednesday Apr 24, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
InflaRx NV | 81.8M | -1.6x | --- |
PMV Pharmaceuticals Inc | 88.0M | -1.2x | --- |
Tiziana Life Sciences Ltd | 86.0M | -5.3x | --- |
Allakos Inc | 88.8M | -0.5x | --- |
Sellas Life Sciences Group Inc | 85.5M | -1.1x | --- |
Genelux Corp | 89.2M | -2.7x | --- |
Company Information
Inflarx NV, formerly Fireman BV, is a holding company for InflaRx GmbH, a Germany-based clinical-stage biopharmaceutical company. The Company's primary focus is on the development of monoclonal antibodies targeting activation products of the complement system for application in the treatment of life-threatening inflammatory diseases. Its lead product candidate, IFX-1, is an intravenously delivered first-in-class anti-C5a monoclonal antibody, undergoing Phase II clinical trial for the treatment of Hidradenitis Suppurativa (HS), a rare and chronic debilitating systemic inflammatory skin disease, and entering Phase II clinical trial for the treatment of ANCA-associated vasculitis (AAV) and other rare autoimmune diseases. The Company's product pipeline also includes IFX-2, which is in preclinical development.
Contact Information
- Headquarters
- Winzerlaer Str. 2JENA, Germany 07745
- Phone
- 364-150-8180
- Fax
- ---
Executives
- Independent Chairman of the Board
- Nicolas Fulpius
- Chief Executive Officer, Executive Director
- Niels Riedemann
- Chief Financial Officer
- Thomas Taapken
- Chief Scientific Officer, Executive Director
- Renfeng Guo
- Chief Clinical Development Officer
- Korinna Pilz
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $81.8M |
|---|---|
Revenue (TTM) | $67.7K |
Shares Outstanding | 58.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.26 |
EPS | $-0.85 |
Book Value | $1.87 |
P/E Ratio | -1.6x |
Price/Sales (TTM) | 1,209.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -71,181.01% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
